APLT — Applied Therapeutics Share News
0.000.00%
Last trade - 00:00- $15.67m
- $3.73m
- $0.46m
Applied Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Applied Therapeutics announces key leadership appointments
Applied Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Applied Therapeutics Q1 Operating Income USD -25.525 Million
Applied Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Applied Therapeutics Inc - Receives Nasdaq Notice For Minimum Bid Price Non-Compliance
Brief: Applied Therapeutics Appoints John H. Johnson As Executive Chairman
Applied Therapeutics says it received FDA's warning letter for genetic disease drug study (updated)
Applied Therapeutics says it received FDA's warning letter for genetic disease drug study
US STOCKS-S&P 500, Dow close at record highs on tech, retail in focus
US STOCKS-S&P 500, Dow close at record highs on tech
Soleno falls after FDA rejects peer Applied's genetic disease drug
US STOCKS-S&P 500 hits record high as major indexes rise on tech, retail stocks
U.S. STOCKS ON THE MOVE-WW Grainger, Silo Pharma, Prologis
Applied Therapeutics falls over 70% as FDA rejects genetic disease drug
U.S. STOCKS ON THE MOVE-Prologis, Malibu Boats, Silo Pharma
U.S. STOCKS ON THE MOVE-Applied Therapeutics, iShares MSCI
U.S. RESEARCH ROUNDUP-Applied Therapeutics, Brown-Forman, Ulta Beauty
Applied Therapeutics sinks after FDA declines to approve genetic disease drug